Results
Bharat Parenterals Q2 FY27 Revenue Up 110.9% YoY
Bharat Parenterals reported Q2 FY27 consolidated revenue of ₹136.3 Cr, up 110.9% YoY, with PAT of ₹11.8 Cr versus a loss of ₹(8.6) Cr in Q2 FY26.
Innoxel Lifesciences, a 55.9% subsidiary, drove profit
